cardiovascular · Mechanism Report
Can LDL particle number be elevated despite optimal LDL cholesterol?
Higher LDL particle number can indicate greater atherogenic burden even when LDL cholesterol is optimal.
This is what AI claimed
LDL particle number can be elevated despite optimal LDL cholesterol, and higher LDL particle number indicates greater atherogenic particle burden because each particle can enter arterial walls.
Executive summary
The claim says LDL-C can look normal while LDL particle number remains elevated, creating discordance between cholesterol mass and particle count. The mechanism frame is that cardiovascular risk tracks more closely with particle concentration because more LDL particles can enter arterial walls, increasing atherogenic burden. Endothelial permeability can further influence how quickly those particles gain access to the vessel wall.
Verified conclusion
Cardiovascular risk assessment in older adults requires precise metrics, as traditional lipid panels measuring cholesterol mass can mask significant atherogenic risk.
Clinical evidence of discordance
- Approximately 20% to 30% of individuals in primary prevention cohorts exhibit discordance, where low-density lipoprotein cholesterol (LDL-C) is optimal but LDL particle number (LDL-P) remains elevated.
- This discordance is highly prevalent in metabolic conditions such as insulin resistance, where cholesteryl ester transfer protein (CETP) activity shifts the profile toward smaller, cholesterol-depleted LDL particles.
- In major cohort studies like the Multi-Ethnic Study of Atherosclerosis (MESA), when discordance occurs, cardiovascular disease risk and subclinical atherosclerosis progression track significantly with LDL-P or its surrogate, apolipoprotein B (apoB), rather than LDL-C.
Mechanistic pathways of atherogenesis
- Transendothelial LDL transport is fundamentally a particle-concentration-driven process. The rate of LDL influx into the arterial intima is determined by the product of circulating LDL-P concentration and endothelial permeability, showing an approximately linear, non-saturable relationship over physiological ranges.
- Once they cross the endothelial barrier via caveolar transcytosis or paracellular leaky junctions, individual particles bind to proteoglycans in the extracellular matrix.
- This entrapment within the subendothelial space initiates a cascade of particle oxidation, macrophage uptake, and foam-cell formation, making each circulating particle an independent vehicle of arterial injury.
Bottom line
- LDL-P is a more direct indicator of cardiovascular risk than LDL-C because vascular particle entry and subsequent plaque formation are concentration-dependent, meaning an elevated particle count drives atherogenesis even when total cholesterol mass appears optimal.
References
- Clinical Implications of Discordance Between LDL Cholesterol ... — pmc.ncbi.nlm.nih.gov
- Are We Moving Towards Concordance on the Principle That Lipid Discordance Matters? — pmc.ncbi.nlm.nih.gov
- Clinical Implications of Discordance Between LDL Cholesterol and LDL Particle Number — linkinghub.elsevier.com
- Discordance of Low-Density Lipoprotein (LDL) Cholesterol ... — ahajournals.org
- Lipid and Lipoprotein Disorders — eguideline.guidelinecentral.com
- Transcytosis of LDL Across Arterial Endothelium: Mechanisms and Therapeutic Targets | Arteriosclerosis, Thrombosis, and Vascular Biology — ahajournals.org
- Transfer of low density lipoprotein into the arterial wall and risk of ... — pubmed.ncbi.nlm.nih.gov
- Transcytosis of LDL Across Arterial Endothelium — ahajournals.org
- Mesoscopic Insights into LDL Transport: A Dissipative Particle Dynamics Study. — asmedigitalcollection.asme.org
- LDL-P - Lipoprotein Particles and Apolipoproteins — healthmatters.io
- The Number of LDL Particles and Cardiovascular risk — biosferteslab.com
- Low-density lipoproteins cause atherosclerotic cardiovascular ... — academic.oup.com
- ApoB vs LDL-C: What Matters Most for Cardiovascular Risk? — drdapo.com
- Targets for LDL-C, ApoB and Small Dense LDL | VAT Trap — vat-trap.com
- [PDF] Apolipoprotein B Particles and Cardiovascular Disease A ... - Sci-Hub — 2024.sci-hub.se
See a full patient report verified like this
Book a walkthrough